New pill formulation for brain conditions tested in healthy volunteers
NCT ID NCT07222878
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 23 times
Summary
This study compared a new soft-gel capsule version of NPT 2042 to the original in 8 healthy adults. The goal was to measure how the drug is absorbed and processed by the body. The results will help guide future dosing for conditions like epilepsy and Alzheimer's disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.